New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

Compare ETFs Easily

The Ultimate ETF Comparison Tool - Try Now!

Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.

Start Comparing ETFs Now!

›ETF Issuers›Global X›EDOG

EDOG

Global X Telemedicine & Digital Health UCITS ETF

Dist

USD

Passive ETF Equity Theme: Healthcare Technology & Innovation

The EDOG Exchange Traded Fund (ETF) is provided by Global X. It is built to track an index: Solactive Telemedicine & Digital Health Index. The EDOG ETF provides physical exposure, so by buying it you actually own parts of all the 38 underlying holdings. This share class generates a stream of income by distributing dividends.

£6.88

-£0.012 (-0.17%) 2 days ago

7:00 AM 08/14/26 Closed

1D price range

£6.88£6.90

52W price range

£7.04£9.36

YTD Perf.

+11.97%

YTD Flows

Annualized volatility

Fund AuM

€5.7M

Share class AuM

€322K

TTM Yield

Tracking Error

Tracking Difference

Characteristics

ISIN

IE00BLR6QC17

TER

0.68%

Inception date

12/17/2020

Issuer

Global X

Benchmark

Solactive Telemedicine & Digital Health Index

Replication method

Dividend policy

Distributing

Compare similar ETFs

ETF Name	1w perf.
EDOC Global X Telemedicine & Digital Health UCITS ETF	+0.78%
HEAL Global X Telemedicine & Digital Health ETF	+2.69%
FMED Fidelity Disruptive Medicine ETF	+1.28%
EKG First Trust Nasdaq Lux Digital Health Solutions ETF	+7.44%
CURE VanEck Genomics and Healthcare Innovators UCITS ETF	+1.14%
PTH Invesco DWA Healthcare Momentum ETF	+0.05%
HELX Franklin Genomic Advancements ETF	-1.92%
FBT First Trust NYSE Arca Biotechnology UCITS ETF	+3.23%
FBT First Trust NYSE Arca Biotechnology Index Fund ETF	+3.23%
FBT First Trust NYSE Arca Biotechnology ETF	+2.51%
CURE Global X S&P Biotech ETF	+1.12%
XBI State Street SPDR S&P Biotech ETF	0.00%
GNOM Global X Genomics & Biotechnology ETF	+0.20%
GNOG Global X Genomics & Biotechnology UCITS ETF	+0.20%
WDNA WisdomTree BioRevolution UCITS ETF	+4.46%

API

PerformanceDec 31, 2025 - Aug 14, 2026

Flows

Join for free to unlock

Sector exposures

Data as of 06/30/26

Healthcare

88.77%

Consumer Non-Cyclicals

7.21%

Unavailable

3.68%

Other

0.33%

Latest EDOG news

No content available for this fund

FAQ about EDOG

EDOG is a Passive ETF. This ETF provides exposure to Equities.

EDOG tracks the Solactive Telemedicine & Digital Health NTR Index - USD, through a full replication replication method.

EDOG carries a total expense ratio (TER) of 0.68%, indicating the annual cost for holding the fund.

EDOG was introduced to the market on December 17, 2020. It trades on Italy, among other exchanges

Global X Telemedicine & Digital Health UCITS ETF, EDOG, is provided by Global X. Learn more about Global X here.

Yes, EDOG is available in multiple share classes, which may differ by distribution policy (e.g., accumulating vs. distributing), currency or hedging. Explore the different share classes .

EDOG oversees €322K in assets as of August 14, 2026.

EDOG follows a distributing dividend policy, meaning it pays out income to investors.

As of June 30, 2026, EDOG has significant geographic allocations in USA, Australia and China.

As of June 30, 2026, EDOG focuses largely on Healthcare and Consumer Non-Cyclicals.

As of June 30, 2026, EDOG holds 38 positions in its portfolio, with 66.72% of assets concentrated in its top 15 holdings.

As of June 30, 2026, EDOG top three holdings include Oscar Health, Inc., Veracyte, Inc. and Twist Bioscience Corp..

The base currency of EDOG is USD.

Top 10 holdings

Data as of 06/30/26

Oscar Health, Inc.

6.56%

Veracyte, Inc.

6.11%

Twist Bioscience Corp.

5.70%

Illumina, Inc.

5.09%

Pro Medicus Ltd.

4.95%

Hims & Hers Health, Inc.

4.22%

DexCom, Inc.

4.04%

IQVIA Holdings, Inc.

4.04%

Agilent Technologies, Inc.

4.03%

Privia Health Group, Inc.

3.92%

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

The Ultimate ETF Comparison Tool - Try Now!

Global X Telemedicine & Digital Health UCITS ETF

FAQ about EDOG

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US